Antiangiogenic activity in chicken fertilized egg chorioallantoic membrane assessed as inhibition of VEGF165-induced vascularization incubated for 2 days by digital camera photography analysis
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as suppression of peritoneal angiogenesis at 100 mg administered on day 7, 9 and 11 post implantation and measured on day 12 by Hematoxylin and eosin staining based assay
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as induction of apoptosis causing apoptotic body formation administered on day 7, 9 and 11 post implantation and measured on day 12 by Giemsa staining based light microscopy
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as induction of apoptosis causing membrane blebbing administered on day 7, 9 and 11 post implantation and measured on day 12 by Giemsa staining based light microscopy
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as induction of apoptosis causing shrinkage of cells administered on day 7, 9 and 11 post implantation and measured on day 12 by Giemsa staining based light microscopy
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as induction of apoptosis causing plasma membrane degradation administered on day 7, 9 and 11 post implantation and measured on day 12 by Giemsa staining based light microscopy
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as increase in mouse survival at 100 mg/kg, ip administered on day 7, 9 and 11 post implantation and measured after 35 days relative to control
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as decrease in ascitic cell viability administered on day 7, 9 and 11 post implantation and measured on day 12 by tryphan blue assay
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as decrease in ascitic fluid administered on day 7, 9 and 11 post implantation and measured on day 12
Antitumor activity against mouse EAT cells implanted in ip dosed Swiss albino mouse assessed as tumor regression administered on day 7, 9 and 11 post implantation and measured on day 12
Toxicity in Swiss albino mouse implanted with mouse EAT cells assessed as decrease in body weight at 100 mg/kg, ip administered on day 7, 9 and 11 post implantation and measured on day 12
Antitumor activity against mouse EAT cells implanted in Swiss albino mouse assessed as tumor suppression at 100 mg/kg, ip administered on day 7, 9 and 11 post implantation and measured on day 12 relative to control